Hedgehog pathway; P glycoprotein (MDR1; ABCB1; P-gp; CD243) BriefCommunication 10 May 2012 Pages: 489 - 489
Peroxisome proliferation–activated receptor-δ (PPARD; PPARδ) BriefCommunication 10 May 2012 Pages: 494 - 494
High mobility group box 1 (HMGB1); IL-1β; tumor necrosis factor-α (TNF-α) BriefCommunication 10 May 2012 Pages: 495 - 495
Peroxisome proliferation–activated receptor-γ (PPARG; PPARGγ) BriefCommunication 10 May 2012 Pages: 496 - 496
Aptamer-based assay against secreted proteins for the identification of new cancer biomarkers BriefCommunication 10 May 2012 Pages: 501 - 501
Algorithm for creating charged antibodies to improve stability and preserve activity BriefCommunication 10 May 2012 Pages: 503 - 503
Dopamine D2 receptor expression as a measure of Huntington's disease (HD) pathology BriefCommunication 10 May 2012 Pages: 504 - 504
Mice with working memory deficits as models of dementia-related delirium BriefCommunication 10 May 2012 Pages: 505 - 505
SH3 and multiple ankyrin repeat domains 2 (SHANK2)-deficient mouse model of autism spectrum disorder (ASD) BriefCommunication 10 May 2012 Pages: 506 - 506
Acyclic cucurbit[n]urils as molecular containers to improve drug solubility BriefCommunication 10 May 2012 Pages: 507 - 507
Gene therapy for Leber's hereditary optical neuropathy (LHON) BriefCommunication 10 May 2012 Pages: 508 - 508
Epigenomic enhancer variants as biomarkers for colorectal cancer BriefCommunication 10 May 2012 Pages: 509 - 509
Genomic and expression analysis–derived breast cancer subgroups to predict response to therapy BriefCommunication 10 May 2012 Pages: 510 - 510